TSLA
Tesla
-- 355.840 NVDA
NVIDIA
-- 138.850 INTC
Intel
-- 23.600 NBIS
NEBIUS
-- 44.490 PLTR
Palantir
-- 119.160 
NEWS
X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia
X4 Pharmaceuticals (Nasdaq: XFOR) will host a virtual investor event on June 27, 2024, at 8:00 AM ET to present new interim results from a Phase 2 clinical trial on mavorixafor for treating chronic neutropenia (CN).
The webcast will showcase hematological data from at least 15 participants, treated either with mavorixafor monotherapy or in combination with G-CSF. Experts will provide insights on the clinical results and the high unmet need in CN treatment.
The company plans to start a global Phase 3 trial in the current quarter to assess the efficacy, safety, and tolerability of mavorixafor in patients with various types of CN facing recurrent infections. A Q&A session will follow the presentation.
The webcast will showcase hematological data from at least 15 participants, treated either with mavorixafor monotherapy or in combination with G-CSF. Experts will provide insights on the clinical results and the high unmet need in CN treatment.
The company plans to start a global Phase 3 trial in the current quarter to assess the efficacy, safety, and tolerability of mavorixafor in patients with various types of CN facing recurrent infections. A Q&A session will follow the presentation.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
8158
Followers
50
Following
93K
Visitors
Follow
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
HBHD : I am holding this stock for at least two years
BeeDeeVee712 HBHD : Same, I think that's a good call (yada che che yada!!!)
Jaguar8 OP BeeDeeVee712 : So don’t forget June 27. Hoping to have a promising clinical trial results.
BeeDeeVee712 : I was kinda assuming positive trial results the 27th were a given for it to be a long-term hold for me, I can’t speak for anyone else, but yes, I’m pumped for the results the 27th!! WOOT WOOTTT LETS GOOOOOO!!!
Jaguar8 OP BeeDeeVee712 : Yes I have the same thought. It’s like more than 3 weeks more. But I think it’s a strategy. The stock will get uptick probably a week before results. This will be like buy the rumors, sell the news type. So put price alerts on this stock